Alterations of the FHIT gene in human hepatocellular carcinoma

FHIT (fragile histidine triad), a candidate tumor suppressor gene, encompasses FRA3B, a region with the highest fragility in the human genome, and is altered in a large number of human cancers, particularly those of epithelial cell origin and associated with known carcinogenic agents. Human hepatoce...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2000-02, Vol.60 (4), p.1049-1053
Main Authors: YUAN, B.-Z, KECK-WAGGONER, C, ZIMONJIC, D. B, THORGEIRSSON, S. S, POPESCU, N. C
Format: Article
Language:English
Subjects:
Acid Anhydride Hydrolases
Biological and medical sciences
Carcinoma, Hepatocellular - genetics
chromosome 3
Chromosome Aberrations
Chromosomes, Human, Pair 3
FHIT gene
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Liver Neoplasms - genetics
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Medical sciences
Neoplasm Proteins
Proteins - analysis
Proteins - genetics
RNA, Messenger - analysis
Tumor Cells, Cultured
Tumors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:FHIT (fragile histidine triad), a candidate tumor suppressor gene, encompasses FRA3B, a region with the highest fragility in the human genome, and is altered in a large number of human cancers, particularly those of epithelial cell origin and associated with known carcinogenic agents. Human hepatocellular carcinoma (HCC), a major cancer worldwide, is closely related to carcinogenic agents such as hepatitis B and C virus infections, dietary aflatoxin, alcohol consumption, and exposure to chemical carcinogens. To assess the extent and the nature of the FHIT gene alterations and their implications in the development of HCC, several cell lines and primary tumors were cytologically and molecularly examined. The FHIT gene is expressed in normal hepatic cells and is not expressed or is abnormally expressed in cultured tumor cells derived from HCC. Down-regulation of the FHIT gene was detected by Northern blot analysis in 9 of 14 cell lines However, neither abnormal FHIT transcripts nor point mutations in DNA sequences of reverse transcription-PCR products (exons 2-9) were identified. Expression of FHIT protein was not detected by immunostaining in 5 of 10 primary tumors. Four cell lines showing mRNA down-regulation did not express FHIT protein as demonstrated by Western blot analysis. Allelic loss of intron 5 of the FHIT gene was detected in 10 of 34 informative samples from primary tumors. Structural alterations of chromosome 3p were identified in 8 of 13 HCC cell lines. Deletions or translocations involving region 3p14.2 were identified by fluorescence in situ hybridization with a YAC850A6 probe spanning the FHIT locus on chromosomes derived from cell lines with an abnormal FHIT gene expression. These combined results indicate that the FHIT gene is a frequent target and may be implicated in a subset of liver cancers.
ISSN:0008-5472
1538-7445